Company Filing History:
Years Active: 2016
Title: Edward Glenn: Innovator in Triterpene Derivatives
Introduction
Edward Glenn is a notable inventor based in Wantage, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on triterpene derivatives. His research focuses on developing novel compounds that have the potential to treat serious health conditions.
Latest Patents
Edward Glenn holds a patent for "Extended triterpene derivatives." This invention concerns novel pharmaceutically active triterpene derivatives and pharmaceutical compositions containing these compounds. The patent outlines their use as medicaments and describes a method of treatment involving the administration of these compounds. Specifically, the compounds are derivatives of betulinic acid with substitutions at one or more of the C-3, C2-8, and C-19 positions. These novel compounds are particularly useful as antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV).
Career Highlights
Edward Glenn is associated with Myrexis, Inc., where he continues to advance his research in pharmaceutical innovations. His work has the potential to impact the treatment of viral infections significantly.
Collaborations
He has collaborated with notable colleagues, including Theodore John Nitz and Christian Montalbetti, to further his research and development efforts.
Conclusion
Edward Glenn's contributions to the field of pharmaceuticals through his innovative triterpene derivatives highlight his role as a key inventor in the industry. His work not only showcases his expertise but also holds promise for future medical advancements.